Back to search

United States· US:0065-0741_e5c0f202-3d32-4b47-8d45-e1d031ff7ce9

Tetracaine Hydrochloride

A tetracaine product containing tetracaine hydrochloride, registered in United States by Alcon Laboratories, Inc.. The same ATC class is registered in 9 of our 19 countries.

ATC S01HA03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTetracaine HydrochlorideATCS01HA03REGISTER NO.US:0065-0741_e5c0f202…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Tetracaine is registered in 9 of 19 countries.

Countries holding a registration under ATC S01HA03 (tetracaine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose

Tetracaine · ATC S01HA03

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TETRACAINE HYDROCHLORIDE
Manufacturer
Alcon Laboratories, Inc.
Country
United States (US)
ATC code
S01HA03
ATC class
Tetracaine
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0065074114
    12 BLISTER PACK in 1 CARTON (0065-0741-14) / 1 BOTTLE, DROPPER in 1 BLISTER PACK / 4 mL in 1 BOTTLE, DROPPER
  • ndc11
    0065-0741-14

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

39 interactions on record for tetracaine.

Graded by severity as the source publishes them — 39 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tetracaine · interactions on record

39 records

  • 39 moderate

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • SulfamethizoleB05CA04moderate
  • LidocaineC01BB01moderate
  • Glyceryl trinitrateC01DA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tetracaine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tetracaine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited, Minims Tetracainehydrochloride Bausch + Lomb Ireland Limited
  • Germany · Tetracain-Hcl Smartpractice Europe
  • Spain · Lubristesic, Tetracaína Lainco
  • France · Tetracaine Thea
  • United Kingdom (Northern Ireland) · Ametop, Anethaine
  • Greece · Tetracaine Hydrochloride Cooper
  • Ireland · Ametop, Minims
  • Luxembourg · Minims, Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited
  • Netherlands · Minims Tetracainehydrochloride, Tetracaïnehydrochloride Minims Bausch + Lomb Ireland
  • Norway · Tetrakain Minims Bausch + Lomb Ireland Limited
  • Sweden · Tetrakain Bausch & Lomb

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce6767d0-0abe-40c4-93a5-be2c59506191
GET /v1/drugs/ce6767d0-0abe-40c4-93a5-be2c59506191?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "OPHTHALMIC",
  "source": "ndc",
  "strength": "5",
  "substance": "TETRACAINE HYDROCHLORIDE",
  "productndc": "0065-0741",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "NDA208135",
  "marketing_category": "NDA"
}

See everything about tetracaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.